MY ACCOUNT | NEWSLETTER |

SeaWorld renews partnership with OCEARCH


Theme park company, SeaWorld Entertainment, Inc., has extended its partnership to support marine research with the non-profit OCEARCH. The goal of the collaboration is to collect scientific data on keystone marine species and to conduct research, educate, and improve knowledge and policy about marine life. 

“Our partnership with SeaWorld has been an important part of making our research possible. They've helped us build out and broaden our science disciplines to maximize the amount of knowledge and data we collect from every animal we sample and release,” said Chris Fischer, founder and expedition leader at OCEARCH. “Their expertise in reproductive biology is leading the way in understanding how white sharks mate, reproduce and give birth. We look forward to continuing to partner with them for many years to maximize the rate at which we can collect data to return our oceans to balance and abundance.”

The partnership has so far included sharing data on animals tagged in order to help preserve and track rehabilitated and released sharks with the publicly available OCEARCH’s Global Shark Tracker. The two groups have also advocated for the preservation and research of marine life with policymakers. 

"Since the beginning of our partnership with OCEARCH, we've been proud to collaborate on the conservation research work done by this community of scientists, all with the common goal of securing a positive future for sharks," said Dr. Chris Dold, the chief zoological officer at SeaWorld Parks & Entertainment.

Like0
Dislike0
  • Please enter a comment


Name *
Email address *
Comment *


* Required fields

Information on the processing of your personal data
We inform you that, in compliance with the provisions of current national and European regulations for the Protection of Personal Data and Services of the Information Society and Electronic Commerce, by sending us this form you are expressly giving your consent to Grupo Asís Biomedia , SL, (hereinafter, "ASIS GROUP") so that, as the person in charge, it may process your personal data in order to respond to your request for contact and information by electronic means.

Likewise, when you expressly consent, we will process your personal data to send you specialized information, newsletters, offers and exclusive promotions from GRUPO ASIS and related companies.

For the aforementioned purpose, GRUPO ASIS may transfer your data to other companies linked to GRUPO ASIS or to third party service providers for the management of electronic communications and other security services, even in cases where they are outside of the European Union, provided that they legally guarantee the adequate level of protection required by European regulations.

At any time you can withdraw the consent given and exercise the rights of access, rectification, deletion, portability of your data and limitation or opposition to its treatment by contacting GRUPO ASIS by sending an email to protecciondatos @ grupoasis.com, or by written communication to address at Centro Empresarial El Trovador, 8th floor, office I, Plaza Antonio Beltrán Martínez 1, 50002, Zaragoza (Spain), indicating in either case the Ref. Personal data and the right you exercise, as well as attaching a copy of your ID or replacement identification document.


I have read and accept the treatment of my data according to the informed purpose and according Legal notes and the Privacy Policy
I wish to receive commercial information from GRUPO ASIS and related companies



More news

EXPRESS: Serum vitamin D metabolites do not differ between cats with chronic kidney disease and healthy cats.

Like0
Dislike0

Assessment of Pancreatic Lipase Activity Using a Quantitative and a Qualitative Assay in Dogs with Chronic Kidney Disease.

Like0
Dislike0

Effects of oregano extracts, alone or in combination with other biomolecules, on growth performances and parasitological parameters of broiler chickens challenged with Eimeria spp.: a meta-analysis.

Like0
Dislike0

New study sets out to elevate asymptomatic COVID-19 surveillance practices

Like0
Dislike0

AB Science : Stonegate Capital Partners updates its coverage of AB Science’s stock with a target price of EUR 4.25 per share

Like0
Dislike0

Newsletter

 
 

News of interest

EVENTS

Copyright © 2026 - All Rights Reserved
ISSN 2768-198X

Top